Literature DB >> 17825315

A new approach for analyzing cellular infiltration during allergic airway inflammation.

Peter R Hoffmann1, Alexandra Gurary, Fukun W Hoffmann, Claude Jourdan-Le Saux, Kelsa Teeters, Ann C Hashimoto, Elizabeth K Tam, Marla J Berry.   

Abstract

A mouse model for allergic airway inflammation involving ovalbumin (OVA) sensitization and challenge has been developed that reproduces hallmark features of human asthma and has provided valuable insight into the mechanisms by which this disease occurs. Cellular infiltrate in lungs of mice used in this model have conventionally been evaluated using histological examination of tissue sections and light microscopic analysis of lung lavage samples. As an alternative or complementary approach for characterizing cellular infiltrate, we developed a multicolor fluorescence-activated cell sorter (FACS) method involving the simultaneous detection of seven different markers on lung cell suspensions: CD4, CD8, B220, CD11b, Gr-1, CD49b, and FcepsilonRI. Only some of these cell types increased in OVA-challenged mice compared to PBS controls, including the CD4(+), B220(+), CD11b(+), and FcepsilonRI(+) groups. We also examined subpopulations of cells for coexpression of these markers and dissected heterogeneous populations as further evaluation procedures to characterize the cellular infiltrate resulting from OVA challenge. Finally, we combined FACS with real-time PCR to analyze certain cell types in terms of mRNA levels for factors involved in asthma, including GATA-3 and IL-1beta. Overall, these FACS-based techniques provide a powerful approach for analyzing cellular profiles in lung tissue from mice used in the mouse model of asthma and may also prove valuable in evaluating cellular infiltrates for other models of inflammation and immune responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825315      PMCID: PMC2864229          DOI: 10.1016/j.jim.2007.07.019

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

Review 1.  Mouse models of allergic airway disease.

Authors:  C M Lloyd; J A Gonzalo; A J Coyle; J C Gutierrez-Ramos
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

2.  A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness.

Authors:  A Tomkinson; C Duez; G Cieslewicz; J C Pratt; A Joetham; M C Shanafelt; R Gundel; E W Gelfand
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.

Authors:  T Springer; G Galfré; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

4.  Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell function.

Authors:  Dianne C Webb; Yeping Cai; Klaus I Matthaei; Paul S Foster
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site of T cell activation during immunotherapy.

Authors:  E M Janssen; A J van Oosterhout; F P Nijkamp; W van Eden; M H Wauben
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

6.  Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite.

Authors:  R J Bischof; K Snibson; R Shaw; E N T Meeusen
Journal:  Clin Exp Allergy       Date:  2003-03       Impact factor: 5.018

7.  Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue.

Authors:  Katja C Beier; Andreas Hutloff; Max Löhning; Tilmann Kallinich; Richard A Kroczek; Eckard Hamelmann
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

8.  Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.

Authors:  K A Ault; T A Springer
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease.

Authors:  Iñigo Goya; Ricardo Villares; Angel Zaballos; Julio Gutiérrez; Leonor Kremer; José-Angel Gonzalo; Rosa Varona; Laura Carramolino; Alfredo Serrano; Pilar Pallarés; Luis Miguel Criado; Roland Kolbeck; Miguel Torres; Anthony J Coyle; José-Carlos Gutiérrez-Ramos; Carlos Martínez-A; Gabriel Márquez
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

10.  Prolonged allergen challenge in mice leads to persistent airway remodelling.

Authors:  S J McMillan; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2004-03       Impact factor: 5.018

View more
  8 in total

1.  Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.

Authors:  Aaron H Rose; FuKun W Hoffmann; Jared H Hara; Johann Urschitz; Stefan Moisyadi; Peter R Hoffmann; Pietro Bertino
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

2.  Development of defined microbial population standards using fluorescence activated cell sorting for the absolute quantification of S. aureus using real-time PCR.

Authors:  Alice Martinon; Ultan P Cronin; Martin G Wilkinson
Journal:  Mol Biotechnol       Date:  2012-01       Impact factor: 2.695

3.  Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses.

Authors:  Saguna Verma; FuKun W Hoffmann; Mukesh Kumar; Zhi Huang; Kelsey Roe; Elizabeth Nguyen-Wu; Ann S Hashimoto; Peter R Hoffmann
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

4.  FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.

Authors:  Nilesh Dharajiya; Swapnil V Vaidya; Hiroki Murai; Victor Cardenas; Alexander Kurosky; Istvan Boldogh; Sanjiv A Sur
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

5.  Fowlpox-based survivin vaccination for malignant mesothelioma therapy.

Authors:  Pietro Bertino; Maddalena Panigada; Elisa Soprana; Valentina Bianchi; Sabrina Bertilaccio; Francesca Sanvito; Aaron H Rose; Haining Yang; Giovanni Gaudino; Peter R Hoffmann; Antonio Siccardi; Michele Carbone
Journal:  Int J Cancer       Date:  2013-02-25       Impact factor: 7.396

6.  Calpastatin prevents NF-κB-mediated hyperactivation of macrophages and attenuates colitis.

Authors:  Zhi Huang; Aaron H Rose; FuKun W Hoffmann; Ann S Hashimoto; Pietro Bertino; Tobias Denk; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Peter R Hoffmann
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

7.  Pinellia ternata, Citrus reticulata, and their combinational prescription inhibit eosinophil infiltration and airway hyperresponsiveness by suppressing CCR3+ and Th2 cytokines production in the ovalbumin-induced asthma model.

Authors:  In-Soo Ok; Seung-Hyung Kim; Bok-Kyu Kim; Jang-Cheon Lee; Young-Cheol Lee
Journal:  Mediators Inflamm       Date:  2009-08-02       Impact factor: 4.711

8.  Cryptotympana pustulata Extract and Its Main Active Component, Oleic Acid, Inhibit Ovalbumin-Induced Allergic Airway Inflammation through Inhibition of Th2/GATA-3 and Interleukin-17/RORγt Signaling Pathways in Asthmatic Mice.

Authors:  Seung-Hyung Kim; Jung-Hee Hong; Won-Kyung Yang; Hyo-Jung Kim; Hyo-Jin An; Young-Cheol Lee
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.